Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Powell

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
BMC Cancer|June 4, 2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)Hamza Hasan, Matthew P Deek, Ryan Phillips, et al.
Nature Biotechnology|July 9, 2005
Summary recommendations for standardization and reporting of metabolic analysesJohn C Lindon, Jeremy K Nicholson, Elaine Holmes, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
BMC Cancer|June 4, 2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)Hamza Hasan, Matthew P Deek, Ryan Phillips, et al.
Nature Biotechnology|July 9, 2005
Summary recommendations for standardization and reporting of metabolic analysesJohn C Lindon, Jeremy K Nicholson, Elaine Holmes, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
Pageof 8